Smith & Nephew unveils new bone screw; BD gets FDA OK for new diagnostic test;

 @FierceMedDev: Paper Dx could become even cheaper if this new research finding catches on. More | Follow @FierceMedDev

 @MarkHFierce: The U.S. breast implant market will grow modestly in the coming years, Millennium estimates, but Europe's won't. More | Follow @MarkHFierce

 @DamianFierce: Fresh off its $100M IPO, Globus Medical got FDA approval for its spinal disc implant. More | Follow @DamianFierce

> Smith & Nephew ($SNN) is rolling out a new surgical screw designed to prevent its loss during surgery. Release

> Kallo, a medical device and information company based in Ontario, Canada, has raised $2 million in equity funding from Kodiak Capital Group. Release

> BD Diagnostics ($BDX) gained FDA 510(k) clearance covering a new diagnostic test for rapid detection of the respiratory syncytial virus, which can cause pneumonia. Release

> VisionQuest in New Mexico is developing an imaging device that can identify medical problems through an eye screening. Story

> Israel's Argo Medical Technologies, maker of robotic exoskeletons, has chosen Massachusetts for its U.S. headquarters, and the company made a splashy announcement at AdvaMed 2012 alongside Gov. Deval Patrick. More

> ConforMIS has launched iTotal G2 Knee Replacement System, which the company says is the only patient-specific device on the market. News

> California startup Interventional Spine, a maker of percutaneous spinal implants, has raised $1.6 million, MedCity News reports. Item

Biotech News

 @FierceBiotech: Special report: The Top Phase III Disasters of 2012. Report | Follow @FierceBiotech

 @JohnCFierce: First "complete virtuous circle" for crowdfunding biotech model in France. Interesting idea. Hard to pull off. Release | Follow @JohnCFierce

 @RyanMFierce: Nice to see VentiRx deal with Celgene, and a win for a biotech with small virtual staff and big potential. More | Follow @RyanMFierce

> Merck pumped about promising IIb results for once-weekly diabetes drug. Article

> Sarepta shares boom on stellar DMD trial results. Story

Pharma News

@FiercePharma: Novartis drops its legal case against U.K. doc group that nixed Lucentis. The group changed policy after Novartis cut price. More | Follow @FiercePharma

> Celgene's Abraxane delivers in melanoma study. Article

> Sanofi, Bristol revamp Plavix partnership for post-patent world. Story

> Sanofi buying Genfar as it rolls across Latin America. News

Biomarkers News

> Singulex heads for $86.25M flotation. Item

> RNA profiles pinpoint the course of MS. Story

> Biomarkers boost success, cut costs in breast cancer clinical trials. Article

> Singulex heads for $86.25M flotation. More

Drug Delivery News

> Pfizer pays out on Antares drug delivery tech agreement. News

> Nanoparticles getting under your skin? Maybe not, actually. Story

> Noven ADHD patch heads into Phase II. Article

Suggested Articles

The FDA has cleared its first fully disposable duodenoscope, following years of reports of infections being transmitted between patients.

OR-focused AI provider Caresyntax has garnered $45.6 million in new funding and picked up a data analytics firm to broaden its footprint.

A study of Foundation Medicine’s FoundationOne liquid biopsy test found it was able to predict the risk that a person’s breast cancer would return.